Hemoglobinopathies (Sickle Cell Disease and Thalassemia)

Review

In: The EBMT Handbook: Hematopoietic Stem Cell Transplantation and Cellular Therapies [Internet]. 7th edition. Cham (CH): Springer; 2019. Chapter 79.

Authors

Barbara Cappelli¹, Eliane Gluckman², Khaled Ghanem³, Miguel R. Abboud⁴

Book Editors

Enric Carreras¹, Carlo Dufour², Mohamad Mohty³, Nicolaus Kröger⁴

Affiliations

¹ Eurocord-Monacord, Centre Scientifique de Monaco, Monaco, Monaco
² Eurocord, Department of Hematology, Hospital Saint Louis, University Paris-Diderot, Paris, France
³ BASMA Pediatric Oncology Unit, Al Bairouni Hospital, Damascus, Syria
⁴ Department of Pediatrics and Adolescent Medicine, American University of Beirut Medical Center, Beirut, Lebanon

Book Affiliations

¹ Spanish Bone Marrow Donor Registry, Josep Carreras Foundation and Leukemia Research Institute, Catalunya, Barcelona, Spain
² Hematology Unit, IRCCS Giannina Gaslini, Geneva, Switzerland
³ Department of Hematology, Pierre and Marie Curie University, Paris, France
⁴ Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppend, Hamburg, Germany

Excerpt

Sickle cell disease (SCD) is the most common inherited hemoglobinopathy worldwide.

Copyright 2019, EBMT and the Author(s).

Sections

Publication types

Review